{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:08:30Z","timestamp":1785812910656,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"HELIOS Klinikum M\u00fcnchen-West and HELIOS Amper-Klinikum Dachau"},{"name":"Robert Koch Institute and Bavarian Health and Food Safety Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s15010-024-02437-0","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:14:07Z","timestamp":1731590047000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LTT-Validity in diagnosis and therapeutical decision making of neuroborreliosis: a prospective dual-centre study"],"prefix":"10.1007","volume":"53","author":[{"given":"G.","family":"Summer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fingerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sp\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2437_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000213069","volume":"37","author":"Z Hubalek","year":"2009","unstructured":"Hubalek Z. Epidemiology of Lyme Borreliosis. Curr Probl Dermatol. 2009;37:31\u201350. https:\/\/doi.org\/10.1159\/000213069.","journal-title":"Curr Probl Dermatol"},{"issue":"3","key":"2437_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ttbdis.2013.10.010","volume":"5","author":"H Wilking","year":"2014","unstructured":"Wilking H, et Stark K. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009\u20132012. Ticks Tick Borne Dis. 2014;5(3):219\u201324. https:\/\/doi.org\/10.1016\/j.ttbdis.2013.10.010.","journal-title":"Ticks Tick Borne Dis"},{"key":"2437_CR3","doi-asserted-by":"publisher","unstructured":"Rauer S, Kastenbauer S et al. Guidelines for diagnosis and treatment in neurology\u2013 Lyme neuroborreliosis. Ger Med Sci. 2020; 18: Doc03. https:\/\/doi.org\/10.3205\/000279","DOI":"10.3205\/000279"},{"key":"2437_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/82_2009_3","volume":"342","author":"D Gilden","year":"2010","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Neurological Disease produced by Varicella Zoster Virus Reactivation without Rash. Curr Top Microbiol Immunol. 2010;342:243\u201353. https:\/\/doi.org\/10.1007\/82_2009_3.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2437_CR5","doi-asserted-by":"publisher","unstructured":"Stanek G, et Strle F, Pfister HW. Lyme borreliosis. Lancet (2009): What are the indications for lumbar puncture in patients with Lyme disease? Curr Probl Dermatol 2009; 37: 200\u2013206. https:\/\/doi.org\/10.1159\/000213078","DOI":"10.1159\/000213078"},{"issue":"4","key":"2437_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408363.2018.1450353","volume":"55","author":"B Lohr","year":"2018","unstructured":"Lohr B, Fingerle V, Norris DE, Hunfeld K-P. Laboratory diagnosis of Lyme borreliosis: current state of art and future perspectives. Crit Rev Clin Lab Sci. 2018;55(4):219\u201345. https:\/\/doi.org\/10.1080\/10408363.2018.1450353.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"11","key":"2437_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00011-010-0209-1","volume":"59","author":"A Lakos","year":"2010","unstructured":"Lakos A, Reiczigel J, Solymosi N. The positive predictive value of Borrelia burgdorferi serology in the light of symptoms of patients sent to an outpatient service for tick-borne diseases. Inflamm Res. 2010;59(11):959\u201364. https:\/\/doi.org\/10.1007\/s00011-010-0209-1.","journal-title":"Inflamm Res"},{"issue":"1","key":"2437_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, et al. EFNS guidelines on the diagnosis and management on European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8\u201316. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02862.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"2437_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00115-005-2021-7","volume":"77","author":"TA Rupprecht","year":"2006","unstructured":"Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister HW. Cytokine CXCL13\u2013a possible early CSF marker for neuroborreliosis. Nervenarzt. 2006;77(4):470\u20133. https:\/\/doi.org\/10.1007\/s00115-005-2021-7.","journal-title":"Nervenarzt"},{"key":"2437_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1874205X01206010104","volume":"6","author":"V von Baehr","year":"2012","unstructured":"von Baehr V, Doebis C, Volk HD, von Baehr R. The lymphocyte transformation test for borrelia detects active lyme borreliosis and verifies effective antibiotic treatment. Open Neurol J. 2012;6:104\u201312. https:\/\/doi.org\/10.2174\/1874205X01206010104.","journal-title":"Open Neurol J"},{"key":"2437_CR11","doi-asserted-by":"publisher","unstructured":"Dessau RB, Fingerle V, Gray J et al. The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect. 2014;20(10):786-7. https:\/\/doi.org\/10.1111\/1469-0691.12583","DOI":"10.1111\/1469-0691.12583"},{"issue":"12","key":"2437_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","volume":"24","author":"TA Rupprecht","year":"2018","unstructured":"Rupprecht TA, Manz KM, Fingerle V, et al. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect. 2018;24(12):1234\u201340. https:\/\/doi.org\/10.1016\/j.cmi.2018.04.007.","journal-title":"Clin Microbiol Infect"},{"key":"2437_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S1473-3099(22)00205-5","volume":"22","author":"ME Baarsma","year":"2022","unstructured":"Baarsma ME, van de Schoor FR, Gauw SA, et al. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study. Lancet Infect Dis. 2022;22:1388\u201396. https:\/\/doi.org\/10.1016\/S1473-3099(22)00205-5.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2437_CR14","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1128\/IAI.69.12.7437-7444.2001","volume":"69","author":"A Vaz","year":"2001","unstructured":"Vaz A, Glickstein L, Field JA, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun. 2001;69(12):7437\u201344. https:\/\/doi.org\/10.1128\/IAI.69.12.7437-7444.2001.","journal-title":"Infect Immun"},{"issue":"7","key":"2437_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-115-7-533","volume":"115","author":"F Dressler","year":"1991","unstructured":"Dressler F, Yoshinari NH, Steere AC. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med. 1991;115(7):533\u20139. https:\/\/doi.org\/10.7326\/0003-4819-115-7-533.","journal-title":"Ann Intern Med"},{"key":"2437_CR16","unstructured":"Wojciechowska-Koszko I, Kwiatkowski P, Sienkiewicz M, Kowalczyk M, Kowalczyk E, Do\u0142\u0119gowska B. Cross-Reactive Results in Serological Tests for Borreliosis in Patients with Active Viral Infections."},{"key":"2437_CR17","doi-asserted-by":"publisher","unstructured":"Hammond S, Thomson P, Meng X, Naisbitt D. In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs. In: Front Immunol. 2021; https:\/\/doi.org\/10.3389\/fimmu.2021.630530","DOI":"10.3389\/fimmu.2021.630530"},{"issue":"3","key":"2437_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s0934-8840(11)80374-9","volume":"279","author":"C Schempp","year":"1993","unstructured":"Schempp C, Owsianowski M, Lange R, Gollnick H. Comparison of Borrelia burgdorferi ultrasonicate and whole B, burgdorferi cells as a stimulus for T-cell proliferation and GM-CSF secretion in vitro. Zentralbl Bakteriol. 1993;279(3):417\u201325. https:\/\/doi.org\/10.1016\/s0934-8840(11)80374-9.","journal-title":"Zentralbl Bakteriol"},{"issue":"2","key":"2437_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.idc.2007.12.013","volume":"22","author":"K Tilly","year":"2008","unstructured":"Tilly K, Patricia AR, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am. 2008;22(2):217\u201334. https:\/\/doi.org\/10.1016\/j.idc.2007.12.013.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"2437_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/pathogens10030281","volume":"10","author":"C Anderson","year":"2021","unstructured":"Anderson C, Brissette C. The brilliance of Borrelia: mechanisms of host Immune Evasion by Lyme Disease-causing spirochetes. Pathogens. 2021;10(3):281. https:\/\/doi.org\/10.3390\/pathogens10030281.","journal-title":"Pathogens"},{"issue":"3","key":"2437_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2249.1995.tb03134.x","volume":"101","author":"P Forsberg","year":"1995","unstructured":"Forsberg P, Ernerudh J, Ekerfelt C, Roberg M, Vrethem M, Bergstr\u00f6m S. The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications. Clin Exp Immunol. 1995;101(3):453\u201360. https:\/\/doi.org\/10.1111\/j.1365-2249.1995.tb03134.x.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2437_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0165-5728(97)00118-5","volume":"79","author":"C Ekerfelt","year":"1997","unstructured":"Ekerfelt C, Ernerudh J, Bunikis J, et al. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol. 1997;79(2):155\u201362. https:\/\/doi.org\/10.1016\/s0165-5728(97)00118-5.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2437_CR23","doi-asserted-by":"publisher","first-page":"e01695","DOI":"10.1128\/JCM.01695-17","volume":"56","author":"T van Gorkom","year":"2018","unstructured":"van Gorkom T, Sankatsing SUC, Voet W, et al. An enzyme-linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-secreting T cells cannot discriminate active Lyme Neuroborreliosis from Past Lyme Borreliosis: a prospective study in the Netherlands. J Clin Microbiol. 2018;56(4):e01695\u201317. https:\/\/doi.org\/10.1128\/JCM.01695-17.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2437_CR24","first-page":"583","volume":"41","author":"P H\u00f6rstrup","year":"1973","unstructured":"H\u00f6rstrup P, Ackermann R. Tick born meningopolyneuritis (Garin-Bujadoux, Bannwarth) (author\u2019s transl). Fortschr Neurol Psychiatr Grenzgeb. 1973;41(11):583\u2013606.","journal-title":"Fortschr Neurol Psychiatr Grenzgeb"},{"issue":"3\u20134","key":"2437_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","volume":"14","author":"TA Rupprecht","year":"2008","unstructured":"Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008;14(3\u20134):205\u201312. https:\/\/doi.org\/10.2119\/2007-00091.Rupprecht.","journal-title":"Mol Med"},{"issue":"1\u20132","key":"2437_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jneuroim.2006.02.007","volume":"175","author":"TA Rupprecht","year":"2006","unstructured":"Rupprecht TA, et al. Adhesion of Borrelia garinii to neuronal cells is mediated by the interaction of OspA with proteoglycans. J Neuroimmunol. 2006;175(1\u20132):5\u201311. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.02.007.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2437_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00313849","volume":"233","author":"F Camponovo","year":"1986","unstructured":"Camponovo F, et Meier C. Neuropathy of vasculitic origin in a case of Garin-Boujadoux-Bannwarth syndrome with positive borrelia antibody response. J Neurol. 1986;233(2):69\u201372. https:\/\/doi.org\/10.1007\/BF00313849.","journal-title":"J Neurol"},{"key":"2437_CR28","doi-asserted-by":"publisher","unstructured":"Ubogu EE. Biology of the human blood-nerve barrier in health and disease. Exp Neurol. 2020;328:Artikel113272. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113272","DOI":"10.1016\/j.expneurol.2020.113272"},{"key":"2437_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000213066","volume":"37","author":"G Baranton","year":"2009","unstructured":"Baranton G, de Martino SJ. Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans. Curr Probl Dermtol. 2009;37:1\u201317. https:\/\/doi.org\/10.1159\/000213066.","journal-title":"Curr Probl Dermtol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02437-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T16:27:07Z","timestamp":1743870427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02437-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02437-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Regarding ethical questions, advice was obtained from the Bavarian institutional review board according to \u00a7\u00a015 professional code of Bavarians\u2019 physicians. The design, procedure and objectives of the study were outlined and submitted to the Bavarian Institutional Review Board in March 2014. No objections were raised by written confirmation in April 2014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}